Enovix Corp is trading 10.3% down at $6.57 following renewed concerns regarding its manufacturing and product ramp timelines.
- Reports indicate significant leadership changes within the manufacturing team, including the departure of a key process lead.
- The shifts have heightened investor caution regarding execution risk during a critical scaling phase for the company.